Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2007
08/02/2007CA2637275A1 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
08/02/2007CA2636050A1 Methods for regulating gelation of polysaccharide solutions and uses thereof
08/02/2007CA2597724A1 Cationic lipids and formulated molecular compositions containing them
08/01/2007EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby
08/01/2007EP1813624A1 Methods and compositions for the prevention and treatment of anemia
08/01/2007EP1813288A1 Medicinal composition, medicinal preparation, and combination preparation
08/01/2007EP1813287A1 Type ii cubic liquid crystal composition
08/01/2007EP1813274A1 Medicinal composition, process for producing the same, and method of stabilizing dihydropyridine compound in medicinal composition
08/01/2007EP1813273A1 Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
08/01/2007EP1813272A1 Veterinary use of a lleuromutilin derivate againts ileitis in swine
08/01/2007EP1812494A1 Microparticles and nanoparticles containing a lipopolymer
08/01/2007EP1812460A1 Formulations, methods of production and uses of fgf-20
08/01/2007EP1812115A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
08/01/2007EP1812082A2 Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer
08/01/2007EP1812073A1 Delivery system for topically applied compounds
08/01/2007EP1812072A2 Benzothiazole formulations and use thereof
08/01/2007EP1812071A2 Compounds for nonsense suppression, use of these compounds for the manufacture of a medicament for treating somatic mutation-related diseases
08/01/2007EP1812050A1 Composition comprising vlp and amyloid-beta peptide
08/01/2007EP1812040A2 Synergistic effects of combined administration of mirtazapine and a stimulant compound
08/01/2007EP1812033A2 Method and composition for enhancing anti-angiogenic therapy
08/01/2007EP1812031A2 Compositions and methods for modification of biomolecules
08/01/2007EP1812022A2 Stand-alone film and methods for making the same
08/01/2007EP1812000A1 Aqueous ophthalmic suspension of crystalline rebamipide
08/01/2007EP1811995A1 A transmucosal veterinary composition comprising detomidine
08/01/2007EP1811859A2 Modified plant gums for preparations of active ingredients
08/01/2007EP1745078A4 Method for the purification of albumin conjugates
08/01/2007EP1565754B1 New uses of proteins encoded by ble genes and antibiotics from the bleomycin family
08/01/2007EP1470226B1 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
08/01/2007EP1429741B1 Process for coating solid particles
08/01/2007EP1393732B1 Minoxidil-containing liquid composition
08/01/2007EP1351712B1 Targeted combination immunotherapy of cancer and infectious diseases
08/01/2007EP1301168B1 Storage-stable compositions of glycerol monoalkyl ethers
08/01/2007EP1133277B1 Pharmaceutical aerosol composition containing hfa 227 and hfa 134a
08/01/2007EP1066816B1 Agents promoting laminin production in skin cells
08/01/2007EP1062223B1 Composition containing a precursor capable of being hydrolysed by glucocerebrosidase
08/01/2007CN1329453C Purified cochineal pigment and process for producing the same
08/01/2007CN1329082C Polymer conjugates of interferon beta-1a and their uses
08/01/2007CN1329081C Method for preparing antineoplastic nanometer heat sensitive target medicine carrier
08/01/2007CN1329036C Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
08/01/2007CN1329025C Gels comprising at least one retinoid and benzoyl peroxide
08/01/2007CN1329023C HFA suspension formulations containing an anticholinergic
08/01/2007CN1329022C Hydrophilic biological sticking gel pasting agent and preparation technique thereof
08/01/2007CN1329016C Granulation method of raw medicine component preparation
08/01/2007CN101010106A Conjugates of antibody and Duocarmycin derivatives as antitumor agents
08/01/2007CN101010105A Glycerol branched polyethylene glycol human growth hormone conjugates, process for their preparation, and methods of use thereof
08/01/2007CN101010104A Stable pharmaceutical composition containing benzimidazole derivatives and method of manufacturing the same
08/01/2007CN101010103A Camptothecin derivatives conjugated in position 20 with integrin antagonists.
08/01/2007CN101010081A Mitochondria activators
08/01/2007CN101010073A Nanocoating for improving biocompatibility of medical implants
08/01/2007CN101010066A Stabilised prostaglandin composition
08/01/2007CN101007868A Preparation method of biodegradable nano micelle controlled release formulation
08/01/2007CN101007851A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
08/01/2007CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
08/01/2007CN101007840A Method for keeping activity of active protein under normal temperature
08/01/2007CN101007176A Drug for treating rheumatoid, rheumatic and other bone and joint diseases
08/01/2007CN101007175A Alpha and beta poly (L asparamide) amino acid derivatives cisplatin macromolecule prodrug, preparation method and use thereof
08/01/2007CN101007174A Biodegradable polymer docetaxel bonded drug and preparation method thereof
08/01/2007CN101007173A Anti-angiogene compositions and methods of use
08/01/2007CN101007171A Skeleton slow releasing implant for deworming from dogs and its preparation method
08/01/2007CN101007170A Preparation method of sustained release formulation for treating echinococcosis
08/01/2007CN101007164A Compound ofloxacin injection and its preparation method
08/01/2007CN101007163A Healing agent for intestinal mucosal injury and its preparation method
08/01/2007CN101007155A Gastric-dissolved and enteric-dissolved pills of traditional Chinese medicine capable of strengthening spleen and nourishing intestine and its preparation method
08/01/2007CN101007087A A medicinal ointment for treating burn and its preparation method
08/01/2007CN101007073A Traditional Chinese medicine lotus lotion and its preparation method
08/01/2007CN101007069A A medicinal composition for treating oral ulcer and its preparation method
08/01/2007CN101007065A Cool tea buccal tablets and its preparation method
08/01/2007CN101007060A A medicinal composition for treating respiratory tract infectious disease and its preparation method
08/01/2007CN101007032A Compound sulfathiazole sodium injection liquid and its preparation method
08/01/2007CN101007011A Ginsenoside Rh2 self-emulsifying composition and its preparation method
08/01/2007CN101007008A Ciclesonide medicinal spraying agent and its preparation method
08/01/2007CN101007003A A stable torasemide injection and its preparation method
08/01/2007CN101006998A Taxol drug supported by polymer nanoparticles and its preparation method
08/01/2007CN101006997A Compound taxol and its derivative docetaxel fat emulsion and preparation method
08/01/2007CN101006993A Soluble slow release external applied contraceptive
08/01/2007CN101006992A Propofol freeze-dried emulsion and its preparing method
08/01/2007CN101006991A Slow release preparation of berberine
08/01/2007CN101006990A Slow release preparation of cilostazol
08/01/2007CN101006989A Slow release preparation of alginic sodium diester
08/01/2007CN101006988A Slow release preparation of puerarin
08/01/2007CN101006987A Slow release preparation of erythromycin
08/01/2007CN101006985A Pharmacological composition
08/01/2007CN101006983A Preparation of composite drug-loaded nanoparticles of carboxyl-chitosan and chitosan modified by glycyrrhizanates
08/01/2007CN101006982A Anticancer medicine composition of taxane and its synergist
08/01/2007CN101006980A Anticancer composition containing taxane and alkaloids
08/01/2007CN101006979A Anticancer composition containing taxane and topoenzyme inhibitor
08/01/2007CN101006978A Anticancer medicinal composition containing taxane and alkylating agents
08/01/2007CN101006977A Anticancer medicinal composition containing taxane and hormones drug
08/01/2007CN101006976A Anticancer medicinal composition of loaded taxane and its synergist
08/01/2007CN101006974A Ophthalmic gel and its preparation method
07/2007
07/31/2007US7250546 Patch with an adhesive of a styrene-isoprene-styrene block copolymer, polyisobutylene, a tackifier, a plasticizer and a polyisobutylene; less skin stimulation, excellent in long time store stability, heat stability, favorable tack during use
07/31/2007US7250498 Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer
07/31/2007US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis
07/31/2007US7250423 Methods for synthesizing heterocycles and therapeutic use of the heterocycles for cancers
07/31/2007US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier
07/31/2007US7250177 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
07/31/2007US7250154 Radio-opaque polymeric biomaterials
07/31/2007CA2240705C Cyclosporin-containing soft capsule preparations
07/31/2007CA2217767C Low ph skin-treatment composition
07/31/2007CA2207674C Moisture containing compositions that are spreadable onto and adherable to biomembranes, methods of making and use thereof
1 ... 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 ... 1712